| Literature DB >> 26208170 |
Jared J Tanner1, Thomas H Mareci2, Michael S Okun3, Dawn Bowers1, David J Libon4, Catherine C Price1.
Abstract
OBJECTIVE: The current investigation examined verbal memory in idiopathic non-dementia Parkinson's disease and the significance of the left entorhinal cortex and left entorhinal-retrosplenial region connections (via temporal cingulum) on memory impairment in Parkinson's disease.Entities:
Mesh:
Year: 2015 PMID: 26208170 PMCID: PMC4514873 DOI: 10.1371/journal.pone.0133792
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Parkinson’s Disease (PD) and Non-PD “Control” Demographics, General Cognition, and Disease Metrics.
| Measure | PD (n = 40) | Control (n = 40) | T | P Value |
|---|---|---|---|---|
| Age | 67.80±5.44, 60/79 | 68.18±4.64, 62/79 | 0.33 | 0.74 |
| Sex (M:F) | 32:8 | 33:7 | -0.28 | 0.78 |
| Education | 16.28±3.03, 10/22 | 16.75±2.35, 12/20 | 0.78 | 0.44 |
| DRS-2 Total | 139.43±3.13, 131/144 | 140.20±2.49, 133/144 | 1.23 | 0.22 |
| WTAR | 107.35±7.68, 86/118 | 108.80±8.76, 81/119 | 0.79 | 0.43 |
| Comorbidity | 0.30±0.72, 0/4 | 0.28±0.61, 0/2 | -0.12 | 0.91 |
| UPDRS Part 3 | 17.60±10.73, 3/46 | 2.75±3.36, 0/15 | -8.36 | 0.00 |
| Disease (yrs) | 7.50±5.15, 1/26 | — | — | — |
| l-Dopa Eq. | 685.69±371.49, 0/1450 | 1.00±6.32, 0/40 | -11.66 | 0.00 |
DRS-2 = Dementia Rating Scale – 2nd Version total raw score (max = 144); WTAR = Wechsler Test of Adult Reading raw score; UPDRS Part 3 = United Parkinson’s Disease Rating Scale Part 3 (Motor) score; Disease duration (yrs) = years of disease duration per self-report/medical records; l-Dopa Equiv. Score = Levodopa Equivalent Score (total daily levodopa dosage intake in milligrams). One control was on levodopa for restless leg syndrome.
Verbal Memory in Parkinson’s disease (PD) and Non-Parkinson’s disease (Non-PD) Raw Mean, Standard Deviation, and Minimum/Maximum scores.
| Measure | PD (n = 40) | Control (n = 40) | P | Eta2 |
|---|---|---|---|---|
| P(r)VLT LDFR | 8.08±2.13, 4/12 | 9.65±2.25, 3/12, | <0.01 | 0.12 |
| P(r)VLT Savings | 84.36± 17.33, 0.40/1.14 | 88.43±14.43, 0.43/1.11 | 0.26 | 0.00 |
| P(r)VLT R. Dis. | 2.94±0.66,1.64/3.93 | 3.41±0.47, 2.32/3.93 | <0.01 | 0.15 |
| Logical Mem. LDFR | 24.62± 7.98, 11/41 | 28.53±5.67, 18/39 | 0.01 | 0.08 |
| Logical Mem. Savings | 81.07±15.60, 47/109 | 88.03±13.93, 37/118 | 0.04 | 0.06 |
| Logical Memory R. Dis. | 2.20±0.94, 0.15/4.26 | 2.86±0.84, 1.46/4.26 | <0.01 | 0.13 |
aP(r)VLT PD sample = 39 due to test exclusion from administration error; all other n = 40 per group.
*Medium effect size
**Large effect size.
LDFR = long delay free recall; R. Discr. = recognition discriminability. Analyses shown in raw form, uncorrected for processing speed or working memory as covariates.
Fig 1Images representative of entorhinal volumetric and fiber tracking results.
Image demonstrating left entorhinal (in red on top panel) and ERC-RSC fibers (temporal cingulum) with entorhinal cortex and retrosplenial region ROIs in orange (bottom panel).
Fig 2Control-based z scores of temporal and frontal-subcortical regions for PD-Well and PD-MI.
*Denotes group difference p<0.05. ERC/TICV = Left entorhinal volume/TICV, Temporal FA = Mean fractional anisotropy of the white matter of the left temporal lobe, Temporal Cingulum EW = Edge weight connectivity of the left temporal cingulum, Frontal thickness = Total mean frontal cortex thickness, Prefrontal FA = Total mean fractional anisotropy of frontal white matter anterior to the rostrum of the corpus callosum, Caudate/TICV = total caudate/TICV, Putamen/TICV = total putamen/TICV, Thalamus/TICV = total thalamus/TICV.